A new OTC option for allergy sufferers.
Chase
S L
SL
D000281:Administration, Intranasal; D004205:Cromolyn Sodium / Q000627:therapeutic use*; D006801:Humans; D006967:Hypersensitivity / Q000188:drug therapy*; D004366:Nonprescription Drugs / Q000627:therapeutic use*; D010353:Patient Education as Topic; D014481:United States; D014486:United States Food and Drug Administration
D004366:Nonprescription Drugs; D004205:Cromolyn Sodium